help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuryshev, Y. A.
Right arrow Articles by Ritchie, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuryshev, Y. A.
Right arrow Articles by Ritchie, A. K.

Endocrinology, Vol 137, 2269-2277, Copyright © 1996 by Endocrine Society


ARTICLES

Corticotropin-releasing hormone stimulates Ca2+ entry through L- and P- type Ca2+ channels in rat corticotropes

YA Kuryshev, GV Childs and AK Ritchie
Department of Physiology and Biophysics, University of Texas Medical Branch, Galveston 77555, USA.

CRH induces corticotrope membrane depolarization and facilitates action potential firing. The increase in electrical excitability causes large oscillatory increases in cytosolic Ca2+ levels. In this study on highly enriched populations of cultured rat corticotropes, inhibitors were used to determine the contribution of the Na+ channel and Ca2+ channel subtypes to membrane excitability and cytosolic Ca2+ levels. Tetrodotoxin, an inhibitor of the voltage-dependent Na+ channel, inhibited a rapid initial component of the action potential, but generally did not influence spontaneous or CRH-induced firing frequency. Tetrodotoxin also had no effect on spontaneous or CRH- induced cytosolic Ca2+ levels. The L-type Ca2+ channel inhibitor nifedipine abolished spontaneous and CRH-induced action potentials and cytosolic Ca2+ transients, but did not eliminate the CRH-induced membrane depolarization or completely restore cytosolic Ca2+ to basal levels. Inhibition of P-type Ca2+ channels with omega-agatoxin-IVA decreased action potential firing frequency and reduced the CRH-induced increase in cytosolic Ca2+. The combination of nifedipine and omega- agatoxin-IVA abolished the CRH-induced rise in Ca2+, but did not abolish the membrane depolarization. Thus, cytosolic Ca2+ is mainly increased by CRH-induced action potentials that are completely dependent on L-type Ca2+ channels and partially regulated by P-type Ca2+ channels. CRH-induced Ca2+ entry also occurs independently of action potentials and is due to P-type, and possibly L-type, Ca2+ channels activated by the CRH-induced membrane depolarization.


This article has been cited by other articles:


Home page
Neural Comput.Home page
N. Toporikova, J. Tabak, M. E. Freeman, and R. Bertram
A-Type K+ Current Can Act as a Trigger for Bursting in the Absence of a Slow Variable
Neural Comput., February 1, 2008; 20(2): 436 - 451.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
I. Murakami, S. Takeuchi, T. Kudo, S. Sutou, and S. Takahashi
Corticotropin-releasing hormone or dexamethasone regulates rat proopiomelanocortin transcription through Tpit/Pitx-responsive element in its promoter
J. Endocrinol., May 1, 2007; 193(2): 279 - 290.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. K. Lee and A. Tse
Dominant Role of Mitochondria in Calcium Homeostasis of Single Rat Pituitary Corticotropes
Endocrinology, November 1, 2005; 146(11): 4985 - 4993.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Soares, M. Thompson, and E. N. Chini
Role of the Second-Messenger Cyclic-Adenosine 5'-Diphosphate-Ribose on Adrenocorticotropin Secretion from Pituitary Cells
Endocrinology, May 1, 2005; 146(5): 2186 - 2192.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Ma, M. J. Shipston, D. Morilak, and J. A. Russell
Reduced Hypothalamic Vasopressin Secretion Underlies Attenuated Adrenocorticotropin Stress Responses in Pregnant Rats
Endocrinology, March 1, 2005; 146(3): 1626 - 1637.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. P. Jedema and A. A. Grace
Corticotropin-Releasing Hormone Directly Activates Noradrenergic Neurons of the Locus Ceruleus Recorded In Vitro
J. Neurosci., October 27, 2004; 24(43): 9703 - 9713.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Yamamori, Y. Iwasaki, Y. Oki, M. Yoshida, M. Asai, M. Kambayashii, Y. Oiso, and N. Nakashima
Possible Involvement of Ryanodine Receptor-Mediated Intracellular Calcium Release in the Effect of Corticotropin-Releasing Factor on Adrenocorticotropin Secretion
Endocrinology, January 1, 2004; 145(1): 36 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Maira, C. Couture, G. Le Martelot, A.-M. Pulichino, S. Bilodeau, and J. Drouin
The T-box Factor Tpit Recruits SRC/p160 Co-activators and Mediates Hormone Action
J. Biol. Chem., November 21, 2003; 278(47): 46523 - 46532.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. A. Antoni, A. A. Sosunov, A. Haunso, J. M. Paterson, and J. Simpson
Short-Term Plasticity of Cyclic Adenosine 3',5'-Monophosphate Signaling in Anterior Pituitary Corticotrope Cells: The Role of Adenylyl Cyclase Isotypes
Mol. Endocrinol., April 1, 2003; 17(4): 692 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. Wiesner, B. Roloff, K. Fechner, and A. Slominski
Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy
J. Cell Sci., April 1, 2003; 116(7): 1261 - 1268.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Maira, C. Martens, E. Batsche, Y. Gauthier, and J. Drouin
Dimer-Specific Potentiation of NGFI-B (Nur77) Transcriptional Activity by the Protein Kinase A Pathway and AF-1-Dependent Coactivator Recruitment
Mol. Cell. Biol., February 1, 2003; 23(3): 763 - 776.
[Abstract] [Full Text]


Home page
FASEB J.Home page
A. SLOMINSKI, J. WORTSMAN, A. PISARCHIK, B. ZBYTEK, E. A. LINTON, J. E. MAZURKIEWICZ, and E. T. WEI
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors
FASEB J, August 1, 2001; 15(10): 1678 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon
Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress
Physiol Rev, July 1, 2000; 80(3): 979 - 1020.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Bonnefont, J. Fiekers, A. Creff, and P. Mollard
Rhythmic Bursts of Calcium Transients in Acute Anterior Pituitary Slices
Endocrinology, March 1, 2000; 141(3): 868 - 875.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. G. Iglesias, G. Diaz-Torga, V. Lux-Lantos, C. Libertun, and D. Becu-Villalobos
Calcium influx and intracellular stores in angiotensin II stimulation of normal and hyperplastic pituitary cells
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E455 - E463.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. Engler, E. Redei, and I. Kola
The Corticotropin-Release Inhibitory Factor Hypothesis: A Review of the Evidence for the Existence of Inhibitory as Well as Stimulatory Hypophysiotropic Regulation of Adrenocorticotropin Secretion and Biosynthesis
Endocr. Rev., August 1, 1999; 20(4): 460 - 500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Ligon, A. E. Boyd III, and K. Dunlap
Class A Calcium Channel Variants in Pancreatic Islets and Their Role in Insulin Secretion
J. Biol. Chem., May 29, 1998; 273(22): 13905 - 13911.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Yu and P. Shinnick-Gallagher
Corticotropin-Releasing Factor Increases Dihydropyridine- and Neurotoxin-Resistant Calcium Currents in Neurons of the Central Amygdala
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 170 - 179.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society